Wolfgang C. Winkelmayer - Publications, H-index & Citations

Wolfgang C. Winkelmayer

Baylor College of Medicine

90H指数

663论文数

3.0W被引数

收录论文 330

发表时间

Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study 类风湿关节炎合并慢性肾脏病患者中生物制剂和靶向合成治疗的有效性与持久性：一项多中心、前瞻性队列研究

The Lancet Rheumatology

IF0

2026-04-22

PREAI

Sho Fukui; Hilde S Ørbo; Sara K Tedeschi; Zeynep S Tuzun; Hongshu Guan; Leslie R Harrold; Heather J Litman; Tomohiro Shinozaki; Mitsumasa Kishimoto; Yoshinori Komagata; Takeaki Matsuda; Wolfgang C Winkelmayer; Daniel H Solomon

In Reply to: “Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation” and “Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation”回复“揭示生存获益：透析抗凝中的血管脆性与选择偏倚”和“新诊断心房颤动血液透析患者阿哌沙班起始应用”

American Journal of Kidney Diseases

IF8.2

2026-04-09

PREAI

Wolfgang C. Winkelmayer; Tara I. Chang

Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis 阿哌沙班在血液透析的肾衰竭患者中新发房颤起始治疗的有效性与安全性

American Journal of Kidney Diseases

IF8.2

2025-12-04

PREAI

Wolfgang C. Winkelmayer; Kevin F. Erickson; Pascale Khairallah; Mingyue He; Maria E. Montez-Rath; Tara I. Chang; Jingbo Niu

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease-Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis-Stimulating Agent Dose 维达环素(vadadustat)与达贝泊汀α(darbepoetin alfa)治疗接受透析的慢性肾病相关贫血的疗效与安全性：基于基线促红细胞生成剂剂量的比较研究

HEMODIALYSIS INTERNATIONAL

IF1.2

2025-12-01

OAAI

Jardine, Alan; Burke, Steven K.; Luo, Wenli; Minga, Todd; Sarnak, Mark J.; Winkelmayer, Wolfgang C.; Agarwal, Rajiv; Chertow, Glenn M.; Eckardt, Kai-uwe; Koury, Mark J.

Preoperative Dialysis Dose and Postoperative Outcomes in Patients Receiving Maintenance Hemodialysis

KIDNEY360

IF3

2025-11-01

PREAI

Fielding-Singh, Vikram; Vanneman, Matthew W.; Morris, Arden M.; Winkelmayer, Wolfgang C.; Sun, Louise Y.; Roshanov, Pavel S.; Montez-Rath, Maria E.; Chertow, Glenn M.; Lin, Eugene

Utilization of telemedicine for patients receiving in-center hemodialysis in the United States 利用远程医疗为在美国接受中心血液透析的患者提供服务

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

OAAI

Niu, Jingbo; Rosales, Omar; Oluyomi, Abiodun; Lew, Susie; Chertow, Glenn; Winkelmayer, Wolfgang; Erickson, Kevin

A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis (vol 33, pg 2059, 2022)《美国血液透析和腹膜透析的医疗保险支出比较》（vol 33, pg 2059, 2022）

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF9.4

2025-10-01

PREAI

Kaplan, Jennifer M.; Niu, Jingbo; Ho, Vivian; Winkelmayer, Wolfgang C.; Erickson, Kevin F.

Association between Access to Alternatives to Daytime In-Center Hemodialysis and Employment among Patients with Kidney Failure 日间中心血液透析替代治疗方案的可及性与肾功能衰竭患者就业之间的关联

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2025-10-01

PREAI

Perez, Jose; Niu, Jingbo; Baerman, Elliot; Winkelmayer, Wolfgang C.; Cavanaugh, Kerri L.; Pappadis, Monique R.; Erickson, Kevin F.

A win-ratio analysis of the cardiovascular safety of vadadustat in patients with CKD-related anemia undergoing dialysis vadadustat在透析的CKD相关性贫血患者中心血管安全性的胜率比分析

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

PREAI

Chertow, Glenn; Burke, Steven; Luo, Wenli; Minga, Todd; Sarnak, Mark; Winkelmayer, Wolfgang; Eckardt, Kai-Uwe

Nephrologist Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study 肾科医生对在中心血液透析期间使用远程医疗的看法：一项定性研究

American Journal of Kidney Diseases

IF8.2

2025-09-19

PREAI

Trenton M. Haltom; Susie Q. Lew; Wolfgang C. Winkelmayer; Glenn M. Chertow; Allison Jaure; Kevin F. Erickson

Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 女性与肾脏健康：KDIGO争议会议的结论

Kidney International

IF12.6

2025-05-28

OAAI

Giorgina Barbara Piccoli; Sofia B. Ahmed; Fadi Fakhouri; Vesna D. Garovic; Michelle A. Hladunewich; Shilpanjali Jesudason; Jai Prakash; Angela C. Webster; Elena Zakharova; Michael Cheung; Jennifer M. King; Michel Jadoul; Wolfgang C. Winkelmayer; Christina M. Wyatt

Corrigendum to “Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.” Kidney International 2025;107:169–179 勘误：“3.0 mmol/l透析液钾浓度与锆基环硅酸盐相比，在无透析日对高钾血症血液透析患者心律失常发生率的影响，以及2.0 mmol/l透析液钾浓度单独使用对心律失常发生率的影响。”《肾脏国际杂志》2025;107:169–179

Kidney International

IF12.6

2025-05-20

OAAI

David M. Charytan; Wolfgang C. Winkelmayer; Christopher B. Granger; John P. Middleton; Charles A. Herzog; Glenn M. Chertow; James M. Eudicone; Jeremy D. Whitson; James A. Tumlin;

The Standardized Outcomes in Nephrology (SONG) initiative: a decade of harmonizing patient voices and research in kidney disease 标准化肾脏病学结局（SONG）倡议：调和肾脏病患者声音与研究的一 decade

Kidney International

IF12.6

2025-05-20

PREAI

Colm O’Reilly; Jonathan C. Craig; Younghee Cho; Sally Crowe; John S. Gill; Brenda Hemmelgarn; Martin Howell; Anastasia Hughes; Angela Ju; Karine Manera; Braden Manns; Roberto Pecoits-Filho; Benedicte Sautenet; Nicole Scholes-Robertson; Armando Teixeira-Pinto; Peter Tugwell; Wim Van Biesen; Andrea K. Viecelli; Angela Yee-Moon Wang; Wolfgang C. Winkelmayer; Allison Jaure

Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States 美国首次移植受者中肾移植失败的趋势

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2025-03-01

OAAI

Khairallah, P; Lorenz, EC; Waterman, A; Aggarwal, N; Pai, AK; Winkelmayer, WC; Niu, JB

Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities 动静脉通路在血液透析起始时位于前臂与上臂位置的对比：时间趋势与种族差异

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2025-02-01

PREAI

Worsley, ML; Niu, JB; Erickson, KF; Barshes, NR; Winkelmayer, WC; Gregg, LP

Oral Anticoagulant Initiation in Patients With Kidney Failure on Hemodialysis Newly Diagnosed With Atrial Fibrillation (2007-2020): An Observational Study of Trends and Disparities

KIDNEY MEDICINE

IF3.4

2025-02-01

OAAI

Winkelmayer, Wolfgang C.; Hu, Austin; Khairallah, Pascale; Airy, Medha; Erickson, Kevin F.; Chang, Tara I.; Niu, Jingbo

Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia 3.0 mmol/l透析液钾浓度下，钠锆环硅酸盐对无透析日与2.0 mmol/l透析液钾浓度单独使用对心房颤动发生率的比较，在伴有高钾血症的血液透析患者中的应用。

KIDNEY INTERNATIONAL

IF12.6

2025-01-01

OAAI

Charytan, David M.; Winkelmayer, Wolfgang C.; Granger, Christopher B.; Middleton, John P.; Herzog, Charles A.; Chertow, Glenn M.; Eudicone, James M.; Whitson, Jeremy D.; Tumlin, James A.

Alzheimer Disease-Related - Related Biomarkers in Patients on Maintenance Hemodialysis

KIDNEY MEDICINE

IF3.4

2024-11-01

OAAI

Masurkar, Arjun, V; Bansal, Nisha; Prince, David K.; Winkelmayer, Wolfgang C.; Ortiz, Daniela F.; Ramos, Gianna; Soomro, Qandeel; Vedvyas, Alok; Osorio, Ricardo S.; Bernard, Mark A.; Debure, Ludovic; Ahmed, Wajiha; Boutajangout, Allal; Wisniewski, Thomas; Charytan, David M.

In advanced CKD, ACEis or ARBs reduce kidney failure vs. placebo or non-RAAS inhibitors at 34 mo

ANNALS OF INTERNAL MEDICINE

IF15.2

2024-10-01

PREAI

Bolona, Carlos E. Aguilar; Winkelmayer, Wolfgang C.

Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making 高钾血症管理决策的前瞻性研究TRACK的设计和队列特征

CLINICAL KIDNEY JOURNAL

IF4.6

2024-09-30

OAAI

Hsia, Judith; Shivappa, Nitin; Bakhai, Ameet; Bover, Jordi; Butler, Javed; Ferraro, Pietro Manuel; Fried, Linda; Schneider, Markus P.; Tangri, Navdeep; Winkelmayer, Wolfgang C.; Bishop, Meredith; Chen, Hungta; Sundin, Anna-Karin; Bonaca, Marc P.

研究方向